{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:09:12Z","timestamp":1784599752637,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053659"],"award-info":[{"award-number":["R01DA053659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>People who inject drugs living with HIV (PWIDLH) suffer the lowest rates of HIV viral suppression due to episodic injection drug use and poor mental health coupled with poor retention in HIV care. Approximately 44% of PWIDLH along the US-Mexico border are retained in care and only 24% are virally suppressed. This underserved region faces a potential explosion of transmission of HIV due to highly prevalent injection drug use. This protocol describes an optimization trial to promote sustained viral suppression among Spanish-speaking Latinx PWIDLH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The multiphase optimization strategy (MOST) is an engineering-inspired framework for designing and building optimized interventions and guides this intervention. The primary aim is to conduct a 2<jats:sup>4<\/jats:sup>factorial experiment in which participants are randomized to one of 16 intervention conditions, with each condition comprising a different combination of four behavioral intervention components. The components are peer support for methadone uptake and persistence; behavioral activation therapy for depression; Life-Steps medication adherence counseling; and patient navigation for HIV care. Participants will complete a baseline survey, undergo intervention, and then return for 3-,6-,9-, and 12-month follow-up assessments. The primary outcome is sustained viral suppression, defined as viral loads of &lt;\u200940 copies per mL at 6-,9-, and 12-month follow-up assessments. Results will yield effect sizes for each component and each additive and interactive combination of components. The research team and partners will make decisions about what constitutes the optimized multi-component intervention by judging the observed effect sizes, interactions, and statistical significance against real-world implementation constraints. The secondary aims are to test mediators and moderators of the component-to-outcome relationship at the 6-month follow-up assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>We are testing well-studied and available intervention components to support PWIDLH to reduce drug use and improve their mental health and engagement in HIV care. The intervention design will allow for a better understanding of how these components work in combination and can be optimized for the setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>This project was registered at clinicaltrials.gov (NCT05377463) on May 17th, 2022.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12889-023-15172-2","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T14:04:19Z","timestamp":1676037859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A factorial experiment grounded in the multiphase optimization strategy to promote viral suppression among people who inject drugs on the Texas-Mexico border: a study protocol"],"prefix":"10.1186","volume":"23","author":[{"given":"John A.","family":"Sauceda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lechuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Puentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Ludwig-Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina A.","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory O.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joselyn","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montelongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzia","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya V.","family":"Gwadz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten B.","family":"Neilands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"5","key":"15172_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00126334-200304150-00009","volume":"32","author":"A Palepu","year":"2003","unstructured":"Palepu A, Tyndall M, Yip B, O\u2019Shaughnessy MV, Hogg RS, Montaner JSG. Impaired Virologic response to highly active antiretroviral therapy Associated with Ongoing Injection Drug Use. JAIDS J Acquir Immune Defic Syndr. 2003;32(5):522\u20136. https:\/\/doi.org\/10.1097\/00126334-200304150-00009.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1\u20132","key":"15172_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drugalcdep.2011.12.019","volume":"124","author":"T Kerr","year":"2012","unstructured":"Kerr T, Marshall BDL, Milloy M-J, et al. Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Drug Alcohol Depend. 2012;124(1\u20132):108\u201312. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.12.019.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"15172_CR3","first-page":"656","volume":"169","author":"E Wood","year":"2003","unstructured":"Wood E, Montaner JSG, Yip B, et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003;169(7):656\u201361.","journal-title":"CMAJ"},{"issue":"1","key":"15172_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10865-012-9476-3","volume":"37","author":"AJ Blashill","year":"2014","unstructured":"Blashill AJ, Gordon JR, Safren SA. Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use. J Behav Med. 2014;37(1):166\u201372. https:\/\/doi.org\/10.1007\/s10865-012-9476-3.","journal-title":"J Behav Med"},{"issue":"9","key":"15172_CR5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1176\/appi.ajp.160.9.1659","volume":"160","author":"MD Stein","year":"2003","unstructured":"Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression Severity and Drug Injection HIV Risk Behaviors. AJP. 2003;160(9):1659\u201362. https:\/\/doi.org\/10.1176\/appi.ajp.160.9.1659.","journal-title":"AJP"},{"issue":"5","key":"15172_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/09540120120063197","volume":"13","author":"AR Knowlton","year":"2001","unstructured":"Knowlton AR, Latkin CA, Schroeder JR, Hoover DR, Ensminger M, Celentano DD. Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care. 2001;13(5):549\u201359. https:\/\/doi.org\/10.1080\/09540120120063197.","journal-title":"AIDS Care"},{"issue":"5","key":"15172_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/apc.2011.0196","volume":"26","author":"SE Hadland","year":"2012","unstructured":"Hadland SE, Milloy M-J, Kerr T, et al. Young Age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDs. 2012;26(5):274\u201380. https:\/\/doi.org\/10.1089\/apc.2011.0196.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"15172_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10461-014-0928-3","volume":"19","author":"J Feelemyer","year":"2015","unstructured":"Feelemyer J, Des Jarlais D, Arasteh K, Uusk\u00fcla A. Adherence to antiretroviral medications among persons who inject drugs in Transitional, Low and Middle Income Countries: an international systematic review. AIDS Behav. 2015;19(4):575\u201383. https:\/\/doi.org\/10.1007\/s10461-014-0928-3.","journal-title":"AIDS Behav"},{"issue":"4","key":"15172_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.qai.0000186392.26334.e3","volume":"41","author":"A Knowlton","year":"2006","unstructured":"Knowlton A, Arnsten J, Eldred L, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. JAIDS J Acquir Immune Defic Syndr. 2006;41(4):486\u201392. https:\/\/doi.org\/10.1097\/01.qai.0000186392.26334.e3.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"16","key":"15172_CR10","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1097\/QAD.0b013e328363bff2","volume":"27","author":"RP Westergaard","year":"2013","unstructured":"Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS. 2013;27(16):2559\u201366. https:\/\/doi.org\/10.1097\/QAD.0b013e328363bff2.","journal-title":"AIDS"},{"key":"15172_CR11","doi-asserted-by":"crossref","unstructured":"Disparities in Consistent Retention in HIV Care \u2014 11 States and the District of Columbia, 2011\u20132013 Author(s): Sharoda Dasgupta, Alexandra M. Oster, Jianmin Li and H. Irene Hall Source: Morbidity and Mortality Weekly Report, Vol.\u00a065, No. 4. (February 5, 2016), pp.\u00a077\u201382 Published by: Centers for Disease Control & Prevention (CDC)","DOI":"10.15585\/mmwr.mm6504a2"},{"issue":"4","key":"15172_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s10461-016-1585-5","volume":"21","author":"CR Lesko","year":"2017","unstructured":"Lesko CR, Tong W, Moore RD, Lau B, Retention. Antiretroviral therapy use and viral suppression by history of Injection Drug Use among HIV-Infected patients in an urban HIV Clinical Cohort. AIDS Behav. 2017;21(4):1016\u201324. https:\/\/doi.org\/10.1007\/s10461-016-1585-5.","journal-title":"AIDS Behav"},{"key":"15172_CR13","doi-asserted-by":"crossref","unstructured":"Brouwer KC, Case P, Ramos R, Magis-Rodriguez C, Bucardo J, et al. Trends in production, trafficking, and consumption of Methamphetamine and Cocaine in Mexico. Volume 41. Substance Use & Misuse; 2006. pp. 707\u201327.","DOI":"10.1080\/10826080500411478"},{"key":"15172_CR14","unstructured":"Comision Nacional contra las Adicciones. Adicciones y grupos espec\u00edficos: Grupos vulnerables y personas en conflictos con la Ley. Secretaria de Salud. Ediciones Berit: Mexico; CONADIC, 2018."},{"key":"15172_CR15","unstructured":"Centro Nacional para la Prevencion y el Control de VIH y el SIDA. (CENSIDA, 2018). The epidemiology of HIV in drug users. Available from http:\/\/www.censida.salud.gob.mx\/interior\/librosdigitales.html"},{"key":"15172_CR16","doi-asserted-by":"crossref","unstructured":"Frost SDW, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME et al. (2006). Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and Syphilis prevalence.","DOI":"10.1007\/s11524-006-9104-z"},{"key":"15172_CR17","unstructured":"Centro Nacional para la Prevencion y el Control de VIH y el SIDA. (CENSIDA, 2014). HIV treatment cascade in Mexico. Available from http:\/\/www.censida.salud.gob.mx"},{"key":"15172_CR18","unstructured":"Words Matter \u2013 Terms to Use and Avoid When Talking About Addiction. National Institute on Drug Abuse. Accessed on https:\/\/nida.nih.gov\/nidamed-medical-health-professionals\/health-professions-education\/words-matter-terms-to-use-avoid-when-talking-about-addiction"},{"issue":"9","key":"15172_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1086\/630209","volume":"49","author":"P Roux","year":"2009","unstructured":"Roux P, Carrieri MP, Cohen J, et al. Retention in Opioid Substitution treatment: a major predictor of long-term virological success for HIV\u2010Infected injection drug users receiving antiretroviral treatment. CLIN INFECT DIS. 2009;49(9):1433\u201340. https:\/\/doi.org\/10.1086\/630209.","journal-title":"CLIN INFECT DIS"},{"issue":"8","key":"15172_CR20","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/add.12970","volume":"110","author":"L Lappalainen","year":"2015","unstructured":"Lappalainen L, Nolan S, Dobrer S, et al. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids: methadone dose and ART adherence. Addiction. 2015;110(8):1330\u20139. https:\/\/doi.org\/10.1111\/add.12970.","journal-title":"Addiction"},{"issue":"8","key":"15172_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, Mburu G, Welton NJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and Meta-analysis. Clin Infect Dis. 2016;63(8):1094\u2013104. https:\/\/doi.org\/10.1093\/cid\/ciw416.","journal-title":"Clin Infect Dis"},{"key":"15172_CR22","unstructured":"Substance Abuse and Mental Health Services Administration. (SAMHSA; 2019). Bringing recovery supports to scale: Technical assistance center strategy. Accessed July 9, 2019 at https:\/\/www.samhsa.gov\/brss-tacs\/training-technical-assistance"},{"key":"15172_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyg.2019.01052","volume":"10","author":"D Eddie","year":"2019","unstructured":"Eddie D, Hoffman L, Vilsant C, et al. Lived experience in new models of care for substance use disorder: a systematic review of peer recovery support services and recovery coaching. Front Psychol. 2019;10:1\u201312.","journal-title":"Front Psychol"},{"key":"15172_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0272-7358(03)00070-9","volume":"23","author":"DR Hopko","year":"2003","unstructured":"Hopko DR, Lejuez CW, Ruggiero KJ, Eifert GH. Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clin Psychol Rev. 2003;23:699\u2013717.","journal-title":"Clin Psychol Rev"},{"key":"15172_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1037\/0022-006X.74.4.658","volume":"74","author":"S Dimidjian","year":"2006","unstructured":"Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74:658\u201367.","journal-title":"J Consult Clin Psychol"},{"key":"15172_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1037\/0022-006X.76.3.468","volume":"76","author":"KS Dobson","year":"2008","unstructured":"Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol. 2008;76:468\u201377.","journal-title":"J Consult Clin Psychol"},{"key":"15172_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1073191106286951","volume":"13","author":"ME Johnson","year":"2006","unstructured":"Johnson ME, Neal DB, Brems C, Fisher DG. Depression as measured by the Beck Depression Inventory-II among injecting drug users. Assessment. 2006;13:168\u201377.","journal-title":"Assessment"},{"issue":"10","key":"15172_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0005-7967(00)00091-7","volume":"39","author":"SA Safren","year":"2001","unstructured":"Safren SA, Otto W, Worth M. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151\u201362. https:\/\/doi.org\/10.1016\/S0005-7967(00)00091-7.","journal-title":"Behav Res Ther"},{"issue":"8","key":"15172_CR29","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1007\/s10461-013-0538-5","volume":"17","author":"JM Simoni","year":"2013","unstructured":"Simoni JM, Wiebe JS, Sauceda JA, et al. A preliminary RCT of CBT-AD for Adherence and Depression among HIV-Positive Latinos on the U.S.-Mexico Border: the Nuevo D\u00eda Study. AIDS Behav. 2013;17(8):2816\u201329. https:\/\/doi.org\/10.1007\/s10461-013-0538-5.","journal-title":"AIDS Behav"},{"issue":"3","key":"15172_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1037\/a0028208","volume":"80","author":"SA Safren","year":"2012","unstructured":"Safren SA, O\u2019Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404\u201315. https:\/\/doi.org\/10.1037\/a0028208.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"15172_CR31","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2352-3018(16)30206-5","volume":"4","author":"S Kanters","year":"2017","unstructured":"Kanters S, Park JJH, Chan K, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. The Lancet HIV. 2017;4(1):e31\u2013e40. https:\/\/doi.org\/10.1016\/S2352-3018(16)30206-5.","journal-title":"The Lancet HIV"},{"issue":"4","key":"15172_CR32","first-page":"542","volume":"178","author":"W Cunningham","year":"2018","unstructured":"Cunningham W, Weiss RE, Nakazono T, et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail. JAMA. 2018;178(4):542\u201353.","journal-title":"JAMA"},{"issue":"1","key":"15172_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13722-017-0081-1","volume":"12","author":"M Stitzer","year":"2017","unstructured":"Stitzer M, Matheson T, Cunningham C, et al. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017;12(1):16. https:\/\/doi.org\/10.1186\/s13722-017-0081-1.","journal-title":"Addict Sci Clin Pract"},{"issue":"17","key":"15172_CR34","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1097\/QAD.0000000000001987","volume":"32","author":"Y Mizuno","year":"2018","unstructured":"Mizuno Y, Higa DH, Leighton CA, Roland KB, Deluca JB, Koenig LJ. Is HIV patient navigation associated with HIV care continuum outcomes? AIDS. 2018;32(17):2557\u201371. https:\/\/doi.org\/10.1097\/QAD.0000000000001987.","journal-title":"AIDS"},{"issue":"10149","key":"15172_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(18)31487-9","volume":"392","author":"WC Miller","year":"2018","unstructured":"Miller WC, Hoffman IF, Hanscom BS, et al. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. The Lancet. 2018;392(10149):747\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(18)31487-9.","journal-title":"The Lancet"},{"issue":"Supplement 2","key":"15172_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAI.0b013e31815767c4","volume":"46","author":"DW Purcell","year":"2007","unstructured":"Purcell DW, Latka MH, Metsch LR, et al. Results from a Randomized Controlled Trial of a peer-mentoring intervention to reduce HIV transmission and increase Access to Care and Adherence to HIV Medications among HIV-Seropositive Injection Drug users. JAIDS J Acquir Immune Defic Syndr. 2007;46(Supplement 2):35\u2013S47. https:\/\/doi.org\/10.1097\/QAI.0b013e31815767c4.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"15172_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2016.8914","volume":"316","author":"LR Metsch","year":"2016","unstructured":"Metsch LR, Feaster DJ, Gooden L, et al. Effect of patient Navigation with or without Financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a Randomized Clinical Trial. JAMA. 2016;316(2):156. https:\/\/doi.org\/10.1001\/jama.2016.8914.","journal-title":"JAMA"},{"issue":"2","key":"15172_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1037\/0278-6133.22.2.223","volume":"22","author":"A Margolin","year":"2003","unstructured":"Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22(2):223\u20138. https:\/\/doi.org\/10.1037\/0278-6133.22.2.223.","journal-title":"Health Psychol"},{"key":"15172_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-72206-1","volume-title":"Optimization of behavioral, Biobehavioral, and Biomedical Interventions: the multiphase optimization strategy (MOST)","author":"LM Collins","year":"2018","unstructured":"Collins LM. Optimization of behavioral, Biobehavioral, and Biomedical Interventions: the multiphase optimization strategy (MOST). Switzerland: Springer; 2018."},{"key":"15172_CR40","unstructured":"Deseridata F. Effectiveness, Efficiency, Economy and Scalability. Collins LM. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy (MOST). Switzerland:Spring; 2018:pp.\u00a014\u201316."},{"key":"15172_CR41","unstructured":"Martinez H, Casta\u00f1on A. (August, 2019). Ciudad Juarez: Migrants\u2019 Limbo. Available from https:\/\/diario.mx\/juarez\/son-ya-18-mil-migrantes-en-juarez-20190812-1549885.html"},{"key":"15172_CR42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.socscimed.2004.12.024","volume":"61","author":"T Rhodes","year":"2005","unstructured":"Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026\u201344.","journal-title":"Soc Sci Med"},{"issue":"1","key":"15172_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12954-018-0225-y","volume":"15","author":"A Ospina-Escobar","year":"2018","unstructured":"Ospina-Escobar A, Magis-Rodr\u00edguez C, Ju\u00e1rez F, et al. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. Harm Reduct J. 2018;15(1):27.","journal-title":"Harm Reduct J"},{"key":"15172_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/tbm\/ibab146","volume":"12","author":"RR Landoll","year":"2022","unstructured":"Landoll RR, Vargas SE, Samardzic KB, Clark MF, Guastaferro K. The preparation phase in the multiphase optimization strategy (MOST): a systematic review and introduction of a reporting checklist. Translational Behav Med. 2022;12:291\u2013303.","journal-title":"Translational Behav Med"},{"key":"15172_CR45","doi-asserted-by":"crossref","unstructured":"Dziak J. In: Collins LM, Kugler KC, editors. Optimizing the cost-effectiveness of a multicomponent intervention using data from a factorial experiment: considerations, open questions, and tradeoffs among multiple outcomes. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions Advanced Topics; 2018.","DOI":"10.1007\/978-3-319-91776-4_7"},{"key":"15172_CR46","doi-asserted-by":"crossref","unstructured":"Kugler KC, Dziak JJ, Trail J. In: Collins LM, Kugler KC, editors. Coding and interpretation of effects in analysis of data from a factorial experiment. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions Advanced Topics.; 2018.","DOI":"10.1007\/978-3-319-91776-4_6"},{"issue":"2","key":"15172_CR47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","volume":"41","author":"MJ Knol","year":"2012","unstructured":"Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012;41(2):514\u201320. https:\/\/doi.org\/10.1093\/ije\/dyr218.","journal-title":"Int J Epidemiol"},{"issue":"21","key":"15172_CR48","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1001\/jama.2018.6360","volume":"319","author":"K Broglio","year":"2018","unstructured":"Broglio K. Randomization in clinical trials: Permuted Blocks and Stratification. JAMA. 2018;319(21):2223. https:\/\/doi.org\/10.1001\/jama.2018.6360.","journal-title":"JAMA"},{"key":"15172_CR49","unstructured":"Texas Peers Certification. (2020, July 13). https:\/\/texaspeers.org\/certification\/"},{"key":"15172_CR50","unstructured":"Texas Peer Support. (2020, July 13). https:\/\/texaspeersupport.org\/our-trainings"},{"key":"15172_CR51","unstructured":"Substance Abuse and Mental Health Services Administration. (SAMHSA; 2020). What are peer recovery support services? Accessed July 13, 2020 at https:\/\/store.samhsa.gov\/product\/What-Are-Peer-Recovery-Support-Services-\/SMA09-4454?referer=from_search_result"},{"issue":"2","key":"15172_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0145445510390929","volume":"35","author":"CW Lejuez","year":"2011","unstructured":"Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten Year Revision of the brief behavioral activation treatment for Depression: revised treatment Manual. Behav Modif. 2011;35(2):111\u201361. https:\/\/doi.org\/10.1177\/0145445510390929.","journal-title":"Behav Modif"},{"issue":"6","key":"15172_CR53","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/2325957415599212","volume":"14","author":"RL Ramos","year":"2015","unstructured":"Ramos RL, Ferreira-Pinto JB, Loza O. Navigator approach to improve quality of care for vulnerable populations in Mexico. J Int Association Providers AIDS Care. 2015;14(6):516\u201326.","journal-title":"J Int Association Providers AIDS Care"},{"issue":"4","key":"15172_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jama.2012.5927","volume":"308","author":"BR Yehia","year":"2012","unstructured":"Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-Infected patients receiving antiretroviral therapy. JAMA. 2012;308(4):339. https:\/\/doi.org\/10.1001\/jama.2012.5927.","journal-title":"JAMA"},{"key":"15172_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0376-8716(02)00111-4","volume":"68","author":"C Nich","year":"2002","unstructured":"Nich C, Carroll KM. \u2018Intention-to-treat\u2019 meets \u2018missing data\u2019: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend. 2002;68:121\u201330.","journal-title":"Drug Alcohol Depend"},{"key":"15172_CR56","doi-asserted-by":"publisher","unstructured":"Torian LV, Xia Q. Achievement and Maintenance of Viral Suppression in Persons Newly Diagnosed With, New York HIV, City. 2006\u20132009: Using Population Surveillance Data to Measure the Treatment Part of \u201cTest and Treat.\u201d JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;63(3):379\u2013386. https:\/\/doi.org\/10.1097\/QAI.0b013e3182926b02","DOI":"10.1097\/QAI.0b013e3182926b02"},{"issue":"3","key":"15172_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/0962280206075303","volume":"16","author":"JR Carpenter","year":"2007","unstructured":"Carpenter JR, Kenward MG, White IR. Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Stat Methods Med Res. 2007;16(3):259\u201375.","journal-title":"Stat Methods Med Res"},{"issue":"9","key":"15172_CR58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"15172_CR59","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1007\/s10461-015-1283-8","volume":"20","author":"JA Sauceda","year":"2016","unstructured":"Sauceda JA, Johnson MO, Saberi P. Nonadherence as 4-day antiretroviral therapy interruptions: do Depression and Race\/Ethnicity matter as much in the modern antiretroviral therapy era? AIDS Behav. 2016;20(11):2624\u20138.","journal-title":"AIDS Behav"},{"issue":"2","key":"15172_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399. PubMed PMID: ISI: A1997XE13900003.","journal-title":"Soc Probl"},{"key":"15172_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/QAI.0000000000001257","volume":"15","author":"M Gwadz","year":"2017","unstructured":"Gwadz M, Cleland CM, Perlman DC, Hagan H, Jenness SM, Leonard NR, Ritchie AS, Kutnick A. Public health benefit of peer-referral strategies for detecting undiagnosed HIV infection among high-risk heterosexuals in New York City. J Acquir Immune Defic Syndr. 2017;15:499\u2013507.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"15172_CR62","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11414-012-9295-x","volume":"39","author":"MC Nelson","year":"2012","unstructured":"Nelson MC, et al. A procedure for assessing intervention fidelity in experiments testing educational and behavioral interventions. J Behav Health Service Res. 2012;39(4):374\u201396.","journal-title":"J Behav Health Service Res"},{"key":"15172_CR63","doi-asserted-by":"crossref","unstructured":"Diggle PJ, Heagarty P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. Oxford, UK: Oxford University Press; 2002.GLMM","DOI":"10.1093\/oso\/9780198524847.001.0001"},{"issue":"4","key":"15172_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/sim.4431","volume":"31","author":"BC Kahan","year":"2012","unstructured":"Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012;31(4):328\u201340.","journal-title":"Stat Med"},{"key":"15172_CR65","doi-asserted-by":"publisher","unstructured":"VanderWeele TJ, Knol MJ. A Tutorial on Interaction. Epidemiol Methods. 2014;3(1). https:\/\/doi.org\/10.1515\/em-2013-0005.","DOI":"10.1515\/em-2013-0005"},{"key":"15172_CR66","unstructured":"The Decision-Priority Perspective. and Resource Management Principle. Collins LM. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy (MOST). Switzerland:Spring; 2018."},{"issue":"4","key":"15172_CR67","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/03637750903310360","volume":"76","author":"AF Hayes","year":"2009","unstructured":"Hayes AF. Beyond Baron and Kenny: statistical mediation analysis in the New Millennium. Communication Monogr. 2009;76(4):408\u201320. https:\/\/doi.org\/10.1080\/03637750903310360.","journal-title":"Communication Monogr"},{"key":"15172_CR68","unstructured":"Muth\u00e9n B. Applications of casually defined direct and indirect effects in mediation analysis using SEM in Mplus. 2011."},{"key":"15172_CR69","unstructured":"Hayes AF. (2012). PROCESS: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White paper]. Retrieved from http:\/\/www.afhayes.com\/public\/process2012.pdf"},{"key":"15172_CR70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brat.2016.11.001","volume":"98","author":"AF Hayes","year":"2017","unstructured":"Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther. 2017;98:39\u201357. https:\/\/doi.org\/10.1016\/j.brat.2016.11.001.","journal-title":"Behav Res Ther"},{"key":"15172_CR71","unstructured":"NCSS PASS 19 [computer program]. Version 16. Kaysville, Utah:NCSS Statistical Software; 2019."},{"key":"15172_CR72","unstructured":"Power a factorial experiment. : Main effects Collins LM. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions: The Multiphase Optimization Strategy (MOST). Switzerland:Spring; 2018."},{"key":"15172_CR73","doi-asserted-by":"publisher","unstructured":"Verdery AM, Mouw T, Bauldry S, Mucha PJ. Network Structure and Biased Variance Estimation in Respondent Driven Sampling. G\u00f3mez S, ed. PLoS ONE. 2015;10(12):e0145296. https:\/\/doi.org\/10.1371\/journal.pone.0145296","DOI":"10.1371\/journal.pone.0145296"},{"issue":"2","key":"15172_CR74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/sti.2003.007625","volume":"80","author":"RA Crosby","year":"2004","unstructured":"Crosby RA, Rothenberg R. In STI interventions, size matters. Sex Transm Infect. 2004;80(2):82\u20135.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"15172_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1467-9280.2007.01882.x","volume":"18","author":"MS Fritz","year":"2007","unstructured":"Fritz MS, MacKinnon DP. Required sample size to detect the mediated effect. Psychol Sci. 2007;18(3):233\u20139.","journal-title":"Psychol Sci"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-15172-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:26:55Z","timestamp":1701883615000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-15172-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["15172"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-15172-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"HIV care continuum engagement on the U.S.-Mexico Border among PWID is seriously impeded by contextual factors such as drug use stigma, mobility, policing, violence, and access to opiates.Interventions for PWIDLH are typically tested as \u201cpackaged\u201d interventions with multiple components, which obscures the effect of each component, does not provide data on how to refine each component to achieve sustained HIV viral suppression, and may lead to inefficient interventions with inactive or counter-productive components.This study will use the multiphase optimization strategy and an efficient factorial design to estimate the individual and interactive impact of four established intervention components for HIV viral suppression in a real-world setting.Based on findings, we will then design a new efficient multi-component intervention with no inactive or poorly performing components and constraints in place to facilitate its scalability.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contributions to the literature"}},{"value":"The study was approved by the University of Texas at El Paso Institutional Review Board on January 19, 2022 and the University of California, Los Angeles Addiction Medicine Data and Safety Monitoring Board in June of 2022. Informed consent will be provided by participants prior to the study enrollment. All research involving human participants will be performed in accordance with the Declaration of Helsinki and has been approved by an appropriate ethics committee and data and safety monitoring board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}